The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,799.50
Bid: 1,796.00
Ask: 1,796.50
Change: 19.00 (1.07%)
Spread: 0.50 (0.028%)
Open: 1,784.00
High: 1,799.50
Low: 1,780.00
Prev. Close: 1,780.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

17 Oct 2014 15:07

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
17 Oct 2014 11:12

UK MIDDAY BRIEFING: Rolls-Royce Lowers Guidance Again

Read more
17 Oct 2014 10:35

TOP NEWS: Rolls-Royce Shares Lose Power After Revenue Warning

Read more
17 Oct 2014 10:03

PRESS: Glaxo's Ebola Drug To "Come Too Late" For Current Outbreak - BBC

Read more
17 Oct 2014 09:23

Glaxo Gets Positive Results For Anoro Ellipta COPD Treatment

Read more
17 Oct 2014 05:23

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
16 Oct 2014 15:07

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
16 Oct 2014 08:36

UK BROKER RATINGS: Panmure Upgrades Shire To Buy From Hold

Read more
16 Oct 2014 05:16

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
15 Oct 2014 15:05

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
14 Oct 2014 16:55

Geographic split likely for GSK mature drugs sale -sources

By Sophie Sassard and Ben Hirschler LONDON, Oct 14 (Reuters) - GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people with direct knowledge of the process. Pote

Read more
14 Oct 2014 16:41

DIRECTOR DEALINGS: Glaxo Directors, Managers Reinvest Dividends

Read more
13 Oct 2014 09:36

BUZZ-Bavarian Nordic shares up on Ebola vaccine prospects

** Biotech company Bavarian Nordic's shares up 8.6 pct to three-and-a-half year highs. ** Its MVA technology, which can be used to improve Ebola vaccines developed by GlaxoSmithKline and Johnson & Johnson, could foster a biodefence business for the company's segment that could become as big

Read more
13 Oct 2014 09:32

Monday broker round-up UPDATE

Amino Technologies: Northland Capital upgrades to buy with a target price of 100p. Anglo American: Canaccord Genuity initiates with a target price of 1720p and a buy recommendation. Credit Suisse upgrades to outperform with a target price of 1800p. Associated British Foods: Societe Generale upgrade

Read more
9 Oct 2014 13:54

UPDATE 1-S.Africa's Aspen teams up with GSK to extend foothold in Japan

(Adds details) JOHANNESBURG, Oct 9 (Reuters) - South Africa generic drugmaker Aspen Pharmacare Holdings Ltd has teamed up with shareholder GlaxoSmithKline Plc (GSK) to extend its presence in Japan, a lucrative market for low-cost medicines, it said on Thursday. Politicians in the worl

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.